SONOMA PHARMACEUTICALS, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
SONOMA PHARMACEUTICALS, INC. (SNOA) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $58.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-06
- SONOMA PHARMACEUTICALS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $58.00K, a 1.75% increase year-over-year.
- SONOMA PHARMACEUTICALS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-12-31 was $24.00K, a 84.62% increase year-over-year.
- SONOMA PHARMACEUTICALS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $39.00K, a 178.57% increase year-over-year.
- SONOMA PHARMACEUTICALS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $57.00K, a 46.73% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2026 was $255.00K, a 50.00% increase from fiscal 2025.
- SONOMA PHARMACEUTICALS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $170.00K, a 33.33% decline from fiscal 2024.
- SONOMA PHARMACEUTICALS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $255.00K, a 60.71% decline from fiscal 2023.
- SONOMA PHARMACEUTICALS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $649.00K.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $58.00K 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | $255.00K 10-K · filed 2026-06-16 | |||
| 2025-12-31 | $24.00K 10-Q · filed 2026-02-10 | $63.00K derived: sum of 2 quarters · filed 2026-02-10 | $120.00K derived: sum of 3 quarters · filed 2026-08-06 | |
| 2025-09-30 | $39.00K 10-Q · filed 2026-02-10 | $96.00K derived: sum of 2 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $57.00K 10-Q · filed 2026-08-06 | |||
| 2025-03-31 | $170.00K 10-K · filed 2026-06-16 | |||
| 2024-12-31 | $13.00K 10-Q · filed 2026-02-10 | $27.00K derived: sum of 2 quarters · filed 2026-02-10 | $134.00K derived: sum of 3 quarters · filed 2026-02-10 | |
| 2024-09-30 | $14.00K 10-Q · filed 2026-02-10 | $121.00K derived: sum of 2 quarters · filed 2026-02-10 | ||
| 2024-06-30 | $107.00K 10-Q · filed 2026-02-10 | |||
| 2024-03-31 | $255.00K 10-K · filed 2025-06-17 | |||
| 2023-12-31 | $140.00K 10-Q · filed 2025-02-05 | $270.00K derived: sum of 2 quarters · filed 2025-02-05 | $447.00K derived: sum of 3 quarters · filed 2025-02-05 | |
| 2023-09-30 | $130.00K 10-Q · filed 2025-02-05 | $307.00K derived: sum of 2 quarters · filed 2025-02-05 | ||
| 2023-06-30 | $177.00K 10-Q · filed 2025-02-05 | |||
| 2023-03-31 | $649.00K 10-K · filed 2024-06-17 | |||
| 2021-06-30 | $56.00K 10-Q · filed 2021-11-15 | |||
| 2020-09-30 | $160.00K 10-Q · filed 2022-02-11 | $205.00K derived: sum of 2 quarters · filed 2022-02-11 | $504.00K derived: sum of 3 quarters · filed 2022-02-11 | $610.00K derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-06-30 | $45.00K 10-Q · filed 2022-02-11 | $344.00K derived: sum of 2 quarters · filed 2022-02-11 | $450.00K derived: sum of 3 quarters · filed 2022-02-11 | $574.00K derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-03-31 | $299.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-14 | $405.00K derived: sum of 2 quarters · filed 2021-07-14 | $529.00K derived: sum of 3 quarters · filed 2021-07-14 | $801.00K 10-K · filed 2021-07-14 |
| 2019-12-31 | $106.00K 10-Q · filed 2021-02-16 | $230.00K derived: sum of 2 quarters · filed 2021-02-16 | $502.00K 10-Q · filed 2020-02-14 | $781.00K derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-09-30 | $124.00K 10-Q · filed 2021-02-16 | $396.00K 10-Q · filed 2019-11-14 | $675.00K derived: sum of 3 quarters · filed 2021-02-16 | $1.04M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | $272.00K 10-Q · filed 2021-02-16 | $551.00K derived: sum of 2 quarters · filed 2021-02-16 | $919.00K derived: sum of 3 quarters · filed 2021-02-16 | $1.43M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | $279.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-10 | $647.00K derived: sum of 2 quarters · filed 2020-07-10 | $1.16M derived: sum of 3 quarters · filed 2020-07-10 | $1.46M 10-K · filed 2020-07-10 |
| 2018-12-31 | $368.00K 10-Q · filed 2020-02-14 | $877.00K derived: sum of 2 quarters · filed 2020-02-14 | $1.18M 10-Q · filed 2020-02-14 | |
| 2018-09-30 | $509.00K 10-Q · filed 2019-11-14 | $811.00K 10-Q · filed 2019-11-14 | ||
| 2018-06-30 | $302.00K 10-Q · filed 2019-08-13 | |||
| 2018-03-31 | $1.23M 10-K · filed 2019-07-01 | |||
| 2017-03-31 | $1.84M 10-K · filed 2018-06-26 | |||
| 2016-03-31 | $1.96M 10-K · filed 2017-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |